NFKB1 and neoplasm: It seems likely that ionizing radiation may also activate the same NF-κB/IFN-β/MHC I signaling axis, resulting in elevated tumor antigen presentation through MHC I and hence increased tumor cell killing by CTLs, which could represent a potential mechanism for radio-immune sensitization.